PATENT CLAIM ANALYSIS

Application Number: 16299872
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "176000"]

Abstract:
This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.

Claim (Index 12):
The compound of  claim 10 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14394789', '12676701', '09941471', '10771926', '10158464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7822690349509658
- 35 USC 102 Novelty (BERT): 0.5386245570014324
- Combined Prediction Score: 0.7579045871560125
- Mean Citation Score: 280.933014
- Max Citation Score: 377.9358
- Similarity Product: 256.03486085146665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test